Literature DB >> 20803550

p53 and p21(Waf1) are recruited to distinct PML-containing nuclear foci in irradiated and Nutlin-3a-treated U2OS cells.

Hong Shen1, Carl G Maki.   

Abstract

Promyelocytic leukemia nuclear bodies (PML-NBs) are multiprotein complexes that include PML protein and localize in nuclear foci. PML-NBs are implicated in multiple stress responses, including apoptosis, DNA repair, and p53-dependent growth inhibition. ALT-associated PML bodies (APBs) are specialized PML-NBs that include telomere-repeat binding-factor TRF1 and are exclusively in telomerase-negative tumors where telomere length is maintained through alternative (ALT) recombination mechanisms. We compared cell-cycle and p53 responses in ALT-positive cancer cells (U2OS) exposed to ionizing radiation (IR) or the p53 stabilizer Nutlin-3a. Both IR and Nutlin-3a caused growth arrest and comparable induction of p53. However, p21, whose gene p53 activates, displayed biphasic induction following IR and monophasic induction following Nutlin-3a. p53 was recruited to PML-NBs 3-4 days after IR, approximately coincident with the secondary p21 increase. These p53/PML-NBs marked sites of apparently unrepaired DNA double-strand breaks (DSBs), identified by colocalization with phosphorylated histone H2AX. Both Nutlin-3a and IR caused a large increase in APBs that was dependent on p53 and p21 expression. Moreover, p21, and to a lesser extent p53, was recruited to APBs in a fraction of Nutlin-3a-treated cells. These data indicate (1) p53 is recruited to PML-NBs after IR that likely mark unrepaired DSBs, suggesting p53 may either be further activated at these sites and/or function in their repair; (2) p53-p21 pathway activation increases the percentage of APB-positive cells, (3) p21 and p53 are recruited to ALT-associated PML-NBs after Nutlin-3a treatment, suggesting that they may play a previously unrecognized role in telomere maintenance.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20803550      PMCID: PMC3613244          DOI: 10.1002/jcb.22852

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  45 in total

1.  p53 has a direct apoptogenic role at the mitochondria.

Authors:  Motohiro Mihara; Susan Erster; Alexander Zaika; Oleksi Petrenko; Thomas Chittenden; Petr Pancoska; Ute M Moll
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

2.  The Nuclear Protein Database (NPD): sub-nuclear localisation and functional annotation of the nuclear proteome.

Authors:  G Dellaire; R Farrall; W A Bickmore
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

3.  Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.

Authors:  C Scheel; K L Schaefer; A Jauch; M Keller; D Wai; C Brinkschmidt; F van Valen; W Boecker; B Dockhorn-Dworniczak; C Poremba
Journal:  Oncogene       Date:  2001-06-28       Impact factor: 9.867

4.  UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.

Authors:  W Maltzman; L Czyzyk
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

Review 5.  Alternative lengthening of telomeres in mammalian cells.

Authors:  Jeremy D Henson; Axel A Neumann; Thomas R Yeager; Roger R Reddel
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

Review 6.  Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.

Authors:  Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

7.  Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy.

Authors:  Neelam Taneja; Mandel Davis; John S Choy; Michael A Beckett; Rachana Singh; Stephen J Kron; Ralph R Weichselbaum
Journal:  J Biol Chem       Date:  2003-10-15       Impact factor: 5.157

8.  Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1.

Authors:  Guikai Wu; Xianzhi Jiang; Wen-Hwa Lee; Phang-Lang Chen
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

9.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

10.  Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo.

Authors:  Jianyuan Luo; Muyang Li; Yi Tang; Monika Laszkowska; Robert G Roeder; Wei Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  4 in total

Review 1.  Retrotransposon-derived p53 binding sites enhance telomere maintenance and genome protection.

Authors:  Paul M Lieberman
Journal:  Bioessays       Date:  2016-08-19       Impact factor: 4.345

2.  RNF38 encodes a nuclear ubiquitin protein ligase that modifies p53.

Authors:  Jamie E Sheren; C Kenneth Kassenbrock
Journal:  Biochem Biophys Res Commun       Date:  2013-08-22       Impact factor: 3.575

3.  Mammalian target of rapamycin complex 2 regulates inflammatory response to stress.

Authors:  Desmond Mascarenhas; Sheri Routt; Baljit K Singh
Journal:  Inflamm Res       Date:  2012-08-17       Impact factor: 4.575

4.  p21-activated kinase 7 is an oncogene in human osteosarcoma.

Authors:  Kun Han; Yan Zhou; Zhi-Hua Gan; Wei-Xiang Qi; Jian-Jun Zhang; Tao Fen; Wei Meng; Ling Jiang; Zan Shen; Da-Liu Min
Journal:  Cell Biol Int       Date:  2014-08-06       Impact factor: 3.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.